Triple Play: Lilly Acquires Three Developers of Infectious Disease Vaccines for Up-to-$3.8B - Genetic Engineering and Biotechnology News
HealthcarePlatform
Eli Lilly→Three Vaccine Developers
May 26, 2026
Eli Lilly — Acquisitions & M&A Deals
14 dealsTracking 14 M&A deals by Eli Lilly.
Eli Lilly announces acquisition of 3 vaccine makers in $4 billion deal
HealthcarePlatform
Eli Lilly
May 26, 2026
Novo Holdings announces acquisition of portfolio company LimmaTech Biologics by Lilly - Novo Holdings
HealthcareMassachusettsAdd-on
Eli Lilly→LimmaTech Biologics
May 26, 2026
Lilly snaps up Engage to advance non-viral genetic medicines
HealthcareCaliforniaPlatform
Eli Lilly→Engage Biologics
May 20, 2026
Eli Lilly to Acquire Kelonia Therapeutics in $7 Billion Gene Therapy Deal - The Healthcare Technology Report.
HealthcarePlatform
Eli Lilly→Kelonia Therapeutics
May 11, 2026
Centessa Pharmaceuticals plc (0001847903) (Filer) — SEC DEFM14A Filing
HealthcareMerger
Eli Lilly→Centessa Pharmaceuticals
May 7, 2026
Eli Lilly Announces Acquisition of Ajax Therapeutics for $2 Billion
HealthcarePlatform
Eli Lilly→Ajax Therapeutics
Apr 28, 2026
Eli Lilly announces acquisition of Ajax Therapeutics for up to $2.3 billion - WJournalpr
HealthcareMerger
Eli Lilly→Ajax Therapeutics
Apr 27, 2026
Lilly to buy startup Ajax in bid for a better JAK drug
HealthcareAcquisition
Eli Lilly→Ajax Therapeutics
Apr 27, 2026
Lilly boosts ‘in vivo’ cell therapy capabilities with Kelonia buyout
HealthcareNew JerseyPlatform
Eli Lilly→Kelonia Therapeutics
Apr 20, 2026
CE-Ventures announces acquisition of portfolio company CrossBridge Bio by Eli Lilly - ZAWYA
HealthcareTexasAdd-on
Eli Lilly→CrossBridge Bio
Apr 14, 2026
Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep disorder drugs
HealthcarePlatform
Eli Lilly→Centessa
Mar 31, 2026
Eli Lilly Expands Into Sleep Medicine With Centessa Buyout - Centessa Pharmaceuticals (NASDAQ:CNTA), Eli - Benzinga
HealthcareMerger
Eli Lilly→Centessa Pharmaceuticals
Mar 31, 2026
Eli Lilly Enters $1.2 Billion Definitive Agreement to Acquire Ventyx Biosciences - Pharmaceutical Executive
HealthcareMerger
Eli Lilly→Ventyx Biosciences
Jan 8, 2026